Login / Signup

Sub-inhibitory antibiotic treatment selects for enhanced metabolic efficiency.

Sai Varun AduruKarolina SzenkielAnika RahmanMehrose AhmadMaya FabozziRobert P SmithAllison J Lopatkin
Published in: Microbiology spectrum (2024)
The sustained emergence of antibiotic-resistant pathogens combined with the stalled drug discovery pipelines highlights the critical need to better understand the underlying evolution mechanisms of antibiotic resistance. To this end, bacterial growth and metabolic rates are often closely related, and resistant cells have historically been characterized exclusively in the context of growth. However, under antibiotic selection, antibiotics counterintuitively favor cells with fast growth, and slow metabolism. Through an integrated approach of mathematical modeling and experiments, this study thereby addresses the significant knowledge gap of whether antibiotic selection drives changes in metabolism that complement, and/or act independently, of antibiotic resistance phenotypes.
Keyphrases
  • induced apoptosis
  • drug discovery
  • cell cycle arrest
  • healthcare
  • cell death
  • endoplasmic reticulum stress
  • oxidative stress
  • combination therapy
  • multidrug resistant
  • drug induced